{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:57:08Z","timestamp":1792292228447,"version":"4.4.0"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003194","name":"Agent\u00fara Ministerstva \u0160kolstva, Vedy, V\u00fdskumu a \u0160portu SR","doi-asserted-by":"publisher","award":["1\/0037\/22"],"award-info":[{"award-number":["1\/0037\/22"]}],"id":[{"id":"10.13039\/501100003194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030974","name":"Pavol Jozef \u0160af\u00e1rik University in Ko\u0161ice","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100030974","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s40263-024-01093-0","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T04:01:28Z","timestamp":1717387288000},"page":"507-532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Targeting Biometals in Alzheimer\u2019s Disease with Metal Chelating Agents Including Coumarin Derivatives"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0514-8592","authenticated-orcid":false,"given":"Adri\u00e1n","family":"Guck\u00fd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9081-3720","authenticated-orcid":false,"given":"Sl\u00e1vka","family":"Hamu\u013eakov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"key":"1093_CR1","doi-asserted-by":"publisher","unstructured":"Alzheimer\u2019s Association. 2018 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2018. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.001.","DOI":"10.1016\/j.jalz.2018.02.001"},{"key":"1093_CR2","doi-asserted-by":"publisher","DOI":"10.1021\/cb400080f","author":"MG Savelieff","year":"2013","unstructured":"Savelieff MG, Lee S, Liu Y, Lim MH. Untangling amyloid-beta, Tau, and metals in Alzheimer\u2019s disease. Acs Chem Biol. 2013. https:\/\/doi.org\/10.1021\/cb400080f.","journal-title":"Acs Chem Biol"},{"key":"1093_CR3","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-132471","author":"H Kawada","year":"2015","unstructured":"Kawada H, Blessing K, Kiyota T, Woolman T, Winchester L, Kador PF. Effects of multifunctional antioxidants on mitochondrial dysfunction and amyloid-\u03b2 metal dyshomeostasis. J Alzheimers Dis. 2015. https:\/\/doi.org\/10.3233\/JAD-132471.","journal-title":"J Alzheimers Dis"},{"key":"1093_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2016.04.013","author":"MA Santos","year":"2016","unstructured":"Santos MA, Chand K, Chaves S. Recent progress in multifunctional metal chelators as potential drugs for Alzheimer\u2019s disease. Coord Chem Rev. 2016. https:\/\/doi.org\/10.1016\/j.ccr.2016.04.013.","journal-title":"Coord Chem Rev"},{"key":"1093_CR5","doi-asserted-by":"publisher","DOI":"10.2174\/0929867328666210218183032","author":"S Chaves","year":"2021","unstructured":"Chaves S, V\u00e1rnagy K, Santos MA. Recent multi-target approaches on the development of anti-Alzheimer\u2019s agents integrating metal chelation activity. Curr Med Chem. 2021. https:\/\/doi.org\/10.2174\/0929867328666210218183032.","journal-title":"Curr Med Chem"},{"key":"1093_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23020250","author":"A Stefanachi","year":"2018","unstructured":"Stefanachi A, Leonetti F, Pisani L, Catto M, Carotti A. Coumarin: a natural, privileged and versatile scaffold for bioactive compounds. Molecules. 2018. https:\/\/doi.org\/10.3390\/molecules23020250.","journal-title":"Molecules"},{"key":"1093_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2015.00127","author":"AR White","year":"2015","unstructured":"White AR, Kanninen K, Crouch P. Editorial: Metals and neurodegeneration: restoring the balance. Front Aging Neurosci. 2015. https:\/\/doi.org\/10.3389\/fnagi.2015.00127.","journal-title":"Front Aging Neurosci."},{"key":"1093_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2010.04.003","author":"JA Duce","year":"2010","unstructured":"Duce JA, Bush AI. Biological metals and Alzheimer\u2019s disease: implications for therapeutics and diagnostics. Prog Neurobiol. 2010. https:\/\/doi.org\/10.1016\/j.pneurobio.2010.04.003.","journal-title":"Prog Neurobiol"},{"key":"1093_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijdevneu.2011.09.004","author":"E Tiffany-Castiglioni","year":"2011","unstructured":"Tiffany-Castiglioni E, Hong S, Qian Y. Copper handling by astrocytes: insights into neurodegenerative diseases. Int J Dev Neurosci. 2011. https:\/\/doi.org\/10.1016\/j.ijdevneu.2011.09.004.","journal-title":"Int J Dev Neurosci"},{"key":"1093_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041161","author":"MB Leko","year":"2023","unstructured":"Leko MB, Horvat LL, Popova\u010dki E\u0160, Zub\u010di\u0107 K, Hof PR, \u0160imi\u0107 G. Metals in Alzheimer\u2019s disease. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11041161.","journal-title":"Biomedicines"},{"key":"1093_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.12.1685","author":"CW Ritchie","year":"2003","unstructured":"Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R, Li QX, Tammer A, Carrington D, Mavros C, Volitakis I, Xilinas M, Ames D, Davis S, Beyreuther K, Tanzi RE, Masters CL. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol. 2003. https:\/\/doi.org\/10.1001\/archneur.60.12.1685.","journal-title":"Arch Neurol"},{"key":"1093_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207660","author":"HW Ejaz","year":"2020","unstructured":"Ejaz HW, Wang W, Lang M. Copper toxicity links to pathogenesis of Alzheimer\u2019s disease and therapeutics approaches. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21207660.","journal-title":"Int J Mol Sci"},{"key":"1093_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2011.07402.x","author":"PJ Crouch","year":"2011","unstructured":"Crouch PJ, Savva MS, Hung LW, Donnelly PS, Mot AI, Parker SJ, Greenough MA, Volitakis I, Adlard PA, Cherny RA. The Alzheimer\u2019s therapeutic PBT2 promotes amyloid-\u03b2 degradation and GSK3 phosphorylation via a metal chaperone activity. J Neurochem. 2011. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07402.x.","journal-title":"J Neurochem"},{"key":"1093_CR14","doi-asserted-by":"publisher","DOI":"10.1021\/acs.inorgchem.0c02754","author":"KL Summers","year":"2020","unstructured":"Summers KL, Roseman GP, Sopasis GJ, Millhauser GL, Harris HH, Pickering IJ, George GN. Copper(II) Binding to PBT2 differs from that of other 8-hydroxyquinoline chelators: implications for the treatment of neurodegenerative protein misfolding diseases. Inorg Chem. 2020. https:\/\/doi.org\/10.1021\/acs.inorgchem.0c02754.","journal-title":"Inorg Chem"},{"key":"1093_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119267","author":"SC Drew","year":"2023","unstructured":"Drew SC. Chelator PBT2 forms a ternary Cu2+ complex with \u03b2-amyloid that has high stability but low specificity. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24119267.","journal-title":"Int J Mol Sci"},{"key":"1093_CR16","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2012-111346","author":"JRP Prasanthi","year":"2012","unstructured":"Prasanthi JRP, Schrag M, Dasari B, Mararha G, Dickson A, Kirsch WM, Ghribi O. Deferiprone reduces amyloid-\u03b2 and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet. J Alzheimers Dis. 2012. https:\/\/doi.org\/10.3233\/JAD-2012-111346.","journal-title":"J Alzheimers Dis"},{"key":"1093_CR17","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.5158","author":"CY Wang","year":"2013","unstructured":"Wang CY, Xie JW, Xu Y, Wang T, Cai JH, Wang X, Zhao BL, An L, Wang ZY. Trientine reduces BACE-1 activity and mitigates amyloidosis via the AGE\/RAGE\/NF-\u03baB pathway in a transgenic mouse model of Alzheimer\u2019s disease. Antioxid Redox Signal. 2013. https:\/\/doi.org\/10.1089\/ars.2012.5158.","journal-title":"Antioxid Redox Signal"},{"key":"1093_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106100","author":"LB Li","year":"2022","unstructured":"Li LB, Fan YG, Wu WX, Bai CY, Jia MY, Hu JP, Gao HL, Wang T, Zhong ML, Huang XS, Guo C. Novel melatonin-trientine conjugate as potential therapeutic agents for Alzheimer\u2019s disease. Bioorg Chem. 2022. https:\/\/doi.org\/10.1016\/j.bioorg.2022.106100.","journal-title":"Bioorg Chem"},{"key":"1093_CR19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2002.00933.x","author":"R Squitti","year":"2002","unstructured":"Squitti R, Rossini PM, Cassetta E, Moffa F, Pasqualetti P, Cortesi M, Colloca A, Rossi L, Finazzi-Agro\u2019 A. d-Penicillamine reduces serum oxidative stress in Alzheimer\u2019s disease patients. Eur J Clin Investig. 2002. https:\/\/doi.org\/10.1046\/j.1365-2362.2002.00933.x.","journal-title":"Eur J Clin Investig"},{"key":"1093_CR20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M207435200","author":"JT Rogers","year":"2002","unstructured":"Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, Leiter L, McPhee J, Sarang SS, Utsuki T, Greig NH, Lahiri DK, Tanzi RE, Bush AI, Giordano T, Gullans SR. An iron-responsive element type II in the 5\u2032-untranslated region of the Alzheimer\u2019s amyloid precursor protein transcript. J Biol Chem. 2002. https:\/\/doi.org\/10.1074\/jbc.M207435200.","journal-title":"J Biol Chem"},{"key":"1093_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2004.01.005","author":"JY Lee","year":"2004","unstructured":"Lee JY, Friedman JE, Angel I, Kozak A, Koh JY. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice. Neurobiol Aging. 2004. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.01.005.","journal-title":"Neurobiol Aging"},{"key":"1093_CR22","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170518094404","author":"V Lanza","year":"2018","unstructured":"Lanza V, Milardi D, Di Natale G, Pappalardo G. Repurposing copper(II)-chelating drugs for the treatment of neurodegenerative diseases. Curr Med Chem. 2018. https:\/\/doi.org\/10.2174\/0929867324666170518094404.","journal-title":"Curr Med Chem"},{"key":"1093_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00775-019-01712-y","author":"GJ Yang","year":"2019","unstructured":"Yang GJ, Liu H, Ma DL, Leung CH. Rebalancing metal dyshomeostasis for Alzheimer\u2019s disease therapy. J Biol Inorg Chem. 2019. https:\/\/doi.org\/10.1007\/s00775-019-01712-y.","journal-title":"J Biol Inorg Chem"},{"key":"1093_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23092182","author":"L Piemontese","year":"2018","unstructured":"Piemontese L, Vitucci G, Catto M, Laghezza A, Perna FM, Rullo M, Loiodice F, Capriati V, Solfrizzo M. Natural scaffolds with multi-target activity for the potential treatment of Alzheimer\u2019s disease. Molecules. 2018. https:\/\/doi.org\/10.3390\/molecules23092182.","journal-title":"Molecules"},{"key":"1093_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biom11010111","author":"V Poliseno","year":"2021","unstructured":"Poliseno V, Chaves S, Brunetti L, Loiodice F, Carrieri A, Laghezza A, Tortorella P, Magalh\u00e3es JD, Cardoso SM, Santos MA, Piemontese L. Derivatives of tenuazonic acid as potential new multi-target anti-Alzheimer\u2019s disease agents. Biomolecules. 2021. https:\/\/doi.org\/10.3390\/biom11010111.","journal-title":"Biomolecules"},{"key":"1093_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106322","author":"B Kilic","year":"2023","unstructured":"Kilic B, Bardakkaya M, Sagkan RI, Aksakal F, Shakila S, Dogruer DS. New thiourea and benzamide derivatives of 2-aminothiazole as multi-target agents against Alzheimer\u2019s disease: design, synthesis, and biological evaluation. Bioorg Chem. 2023. https:\/\/doi.org\/10.1016\/j.bioorg.2022.106322.","journal-title":"Bioorg Chem"},{"key":"1093_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.12.140","author":"K Wojtunik-Kulesza","year":"2019","unstructured":"Wojtunik-Kulesza K, Oniszczuk A, Waksmundzka-Hajnos M. An attempt to elucidate the role of iron and zinc ions in development of Alzheimer\u2019s and Parkinson\u2019s diseases. Biomed Pharmacother. 2019. https:\/\/doi.org\/10.1016\/j.biopha.2018.12.140.","journal-title":"Biomed Pharmacother"},{"key":"1093_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2004.10.003","author":"ZI Cabantchik","year":"2005","unstructured":"Cabantchik ZI, Breuer W, Zanninelli G, Cianciulli P. LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol. 2005. https:\/\/doi.org\/10.1016\/j.beha.2004.10.003.","journal-title":"Best Pract Res Clin Haematol"},{"key":"1093_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-008-0120-5","author":"Y Kohgo","year":"2008","unstructured":"Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Body iron metabolism and pathophysiology of iron overload. Int J Hematol. 2008. https:\/\/doi.org\/10.1007\/s12185-008-0120-5.","journal-title":"Int J Hematol"},{"key":"1093_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/s0891-5849(02)01006-7","author":"O Kakhlon","year":"2002","unstructured":"Kakhlon O, Cabantchik ZI. The labile iron pool: characterization, measurement, and participation in cellular processes. Free Radic Biol Med. 2002. https:\/\/doi.org\/10.1016\/s0891-5849(02)01006-7.","journal-title":"Free Radic Biol Med"},{"key":"1093_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2007.04.025","author":"H Nick","year":"2007","unstructured":"Nick H. Iron chelation, quo vadis? Curr Opin Chem Biol. 2007. https:\/\/doi.org\/10.1016\/j.cbpa.2007.04.025.","journal-title":"Curr Opin Chem Biol"},{"key":"1093_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2013.00034","author":"D Hare","year":"2013","unstructured":"Hare D, Ayton S, Bush A, Lei P. A delicate balance: iron metabolism and diseases of the brain. Front Aging Neurosci. 2013. https:\/\/doi.org\/10.3389\/fnagi.2013.00034.","journal-title":"Front Aging Neurosci."},{"key":"1093_CR33","first-page":"873","volume":"91","author":"A Piga","year":"2006","unstructured":"Piga A, Galanello R, Forni GL, Cappellini MD, Origa R, Zappu A. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload. Haematologica. 2006;91:873\u201380.","journal-title":"Haematologica"},{"key":"1093_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-009-9070-9","author":"S Gal","year":"2010","unstructured":"Gal S, Zheng H, Fridkin M, Youdim MBH. Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30. Neurotox Res. 2010. https:\/\/doi.org\/10.1007\/s12640-009-9070-9.","journal-title":"Neurotox Res"},{"key":"1093_CR35","doi-asserted-by":"publisher","DOI":"10.2174\/156720510791162403","author":"Y Avramovich-Tirosh","year":"2010","unstructured":"Avramovich-Tirosh Y, Bar-Am O, Amit T, Youdim MBH, Weinreb O. Up-regulation of hypoxia-inducible factor (HIF)-1\u03b1 and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30. Curr Alzheimer Res. 2010. https:\/\/doi.org\/10.2174\/156720510791162403.","journal-title":"Curr Alzheimer Res"},{"key":"1093_CR36","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-8386com","author":"W Zhu","year":"2007","unstructured":"Zhu W, Xie W, Pan T, Xu P, Fridkin M, Zheng H, Jankovic J, Youdim MBH, Le W. Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators. FASEB J. 2007. https:\/\/doi.org\/10.1096\/fj.07-8386com.","journal-title":"FASEB J"},{"key":"1093_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2004.08.023","author":"MBH Youdim","year":"2005","unstructured":"Youdim MBH, Fridkin M, Zheng H. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. Mech Ageing Dev. 2005. https:\/\/doi.org\/10.1016\/j.mad.2004.08.023.","journal-title":"Mech Ageing Dev"},{"key":"1093_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2613","author":"P Lei","year":"2012","unstructured":"Lei P, Ayton S, Finkelstein DI, Spoerri L, Ciccotosto GD, Wright DK, Wong BXW, Adlard PA, Cherny RA, Lam LQ, Roberts BR, Volitakis I, Egan GF, McLean CA, Cappai R, Duce JA, Bush AI. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat Med. 2012. https:\/\/doi.org\/10.1038\/nm.2613.","journal-title":"Nat Med"},{"key":"1093_CR39","doi-asserted-by":"publisher","DOI":"10.3233\/jad-2010-100024","author":"C Li","year":"2010","unstructured":"Li C, Wang J, Zhou B. The metal chelating and chaperoning effects of clioquinol: insights from yeast studies. J Alzheimers Dis. 2010. https:\/\/doi.org\/10.3233\/jad-2010-100024.","journal-title":"J Alzheimers Dis"},{"key":"1093_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2011.01.009","author":"MH Park","year":"2011","unstructured":"Park MH, Lee SJ, Byun HR, Kim Y, Oh YJ, Koh JY, Hwang JJ. Clioquinol induces autophagy in cultured astrocytes and neurons by acting as a zinc ionophore. Neurobiol Dis. 2011. https:\/\/doi.org\/10.1016\/j.nbd.2011.01.009.","journal-title":"Neurobiol Dis"},{"key":"1093_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/s0896-6273(03)00126-0","author":"D Kaur","year":"2003","unstructured":"Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, Boonplueang R, Viswanath V, Jacobs R, Yang L, Beal MF, DiMonte D, Volitakis I, Ellerby L, Cherny RA, Bush AI, Andersen JK. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson\u2019s disease. Neuron. 2003. https:\/\/doi.org\/10.1016\/s0896-6273(03)00126-0.","journal-title":"Neuron"},{"key":"1093_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4911205","author":"S Entezari","year":"2022","unstructured":"Entezari S, Haghi SM, Norouzkhani N, Sahebnazar B, Vosoughian F, Akbarzadeh D, Islampanah M, Naghsh N, Abbasalizadeh M, Deravi N. Iron chelators in treatment of iron overload. J Toxicol. 2022. https:\/\/doi.org\/10.1155\/2022\/4911205.","journal-title":"J Toxicol"},{"key":"1093_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216353","author":"J Wang","year":"2023","unstructured":"Wang J, Fu J, Zhao Y, Liu Q, Yan X, Su J. Iron and targeted iron therapy in Alzheimer\u2019s disease. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242216353.","journal-title":"Int J Mol Sci"},{"key":"1093_CR44","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.0c00474","author":"AC Farr","year":"2021","unstructured":"Farr AC, Xiong MP. Challenges and opportunities of deferoxamine delivery for treatment of Alzheimer\u2019s disease, Parkinson\u2019s disease, and intracerebral hemorrhage. Mol Pharm. 2021. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00474.","journal-title":"Mol Pharm"},{"key":"1093_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1015711","author":"JB Parker","year":"2023","unstructured":"Parker JB, Griffin MF, Downer MA, Akras D, Berry CE, Cotterell AC, Gurtner GC, Longaker MT, Wan DC. Chelating the valley of death: deferoxamine\u2019s path from bench to wound clinic. Front Med. 2023. https:\/\/doi.org\/10.3389\/fmed.2023.1015711.","journal-title":"Front Med"},{"key":"1093_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2023.1234958","author":"OD Schreiner","year":"2023","unstructured":"Schreiner OD, Schreiner TG. Iron chelators as a therapeutic option for Alzheimer\u2019s disease\u2014a mini-review. Front Aging. 2023. https:\/\/doi.org\/10.3389\/fragi.2023.1234958.","journal-title":"Front Aging"},{"key":"1093_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-011-0050-2","author":"LR Hanson","year":"2012","unstructured":"Hanson LR, Fine JM, Renner DB, Svitak AL, Burns RB, Nguyen TM, Tuttle NJ, Marti DL, Panter SS, Frey WH. Intranasal delivery of deferoxamine reduces spatial memory loss in APP\/PS1 mice. Drug Deliv Transl Res. 2012. https:\/\/doi.org\/10.1007\/s13346-011-0050-2.","journal-title":"Drug Deliv Transl Res"},{"key":"1093_CR48","doi-asserted-by":"publisher","DOI":"10.1080\/15376516.2022.2053254","author":"D Zhu","year":"2022","unstructured":"Zhu D, Liang R, Liu Y, Li Z, Cheng L, Ren J, Guo Y, Wang M, Chai H, Niu Q, Yang S, Bai J, Yu H, Zhang H, Qin X. Deferoxamine ameliorated Al(mal)3-induced neuronal ferroptosis in adult rats by chelating brain iron to attenuate oxidative damage. Toxicol Mech Methods. 2022. https:\/\/doi.org\/10.1080\/15376516.2022.2053254.","journal-title":"Toxicol Mech Methods"},{"key":"1093_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2015.00104","author":"C Guo","year":"2015","unstructured":"Guo C, Zhang YX, Wang T, Zhong ML, Yang ZH, Hao LJ, Chai R, Zhang S. Intranasal deferoxamine attenuates synapse loss via up-regulating the P38\/HIF-1\u03b1 pathway on the brain of APP\/PS1 transgenic mice. Front Aging Neurosci. 2015. https:\/\/doi.org\/10.3389\/fnagi.2015.00104.","journal-title":"Front Aging Neurosci."},{"key":"1093_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2012.12.005","author":"C Guo","year":"2013","unstructured":"Guo C, Wang P, Zhong ML, Wang T, Huang XS, Li JY, Wang ZY. Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain. Neurochem Int. 2013. https:\/\/doi.org\/10.1016\/j.neuint.2012.12.005.","journal-title":"Neurochem Int"},{"key":"1093_CR51","doi-asserted-by":"publisher","DOI":"10.2450\/2012.0008-12","author":"E Poggiali","year":"2012","unstructured":"Poggiali E, Cassinerio E, Zanaboni L, Cappellini MD. An update on iron chelation therapy. Blood Transfus. 2012. https:\/\/doi.org\/10.2450\/2012.0008-12.","journal-title":"Blood Transfus"},{"key":"1093_CR52","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.043018","author":"G Abbruzzese","year":"2011","unstructured":"Abbruzzese G, Cossu G, Balocco M, Marchese R, Murgia D, Melis M, Galanello R, Barella S, Matta G, Ruffinengo U, Bonuccelli U, Forni GL. A pilot trial of deferiprone for neurodegeneration with brain iron accumulation. Haematologica. 2011. https:\/\/doi.org\/10.3324\/haematol.2011.043018.","journal-title":"Haematologica"},{"key":"1093_CR53","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-200551","author":"SS Rao","year":"2020","unstructured":"Rao SS, Portbury SD, Lago L, Bush AI, Adlard PA. The iron chelator deferiprone improves the phenotype in a mouse model of tauopathy. J Alzheimers Dis. 2020. https:\/\/doi.org\/10.3233\/JAD-200551.","journal-title":"J Alzheimers Dis"},{"key":"1093_CR54","doi-asserted-by":"publisher","DOI":"10.1039\/c8mt00143j","author":"K Chand","year":"2018","unstructured":"Chand K, Rajeshwari R, Candeias E, Cardoso SM, Chaves S, Santos MA. Tacrine-deferiprone hybrids as multi-target-directed metal chelators against Alzheimer\u2019s disease: a two-in-one drug. Metallomics. 2018. https:\/\/doi.org\/10.1039\/c8mt00143j.","journal-title":"Metallomics"},{"key":"1093_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(08)70007-9","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD. Long-term efficacy and safety of deferasirox. Blood Rev. 2008. https:\/\/doi.org\/10.1016\/S0268-960X(08)70007-9.","journal-title":"Blood Rev"},{"key":"1093_CR56","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-150514","author":"P Banerjee","year":"2016","unstructured":"Banerjee P, Sahoo A, Anand S, Bir A, Chakrabarti S. The oral iron chelator, deferasirox, reverses the age-dependent alterations in iron and amyloid-\u03b2 homeostasis in rat brain: implications in the therapy of Alzheimer\u2019s disease. J Alzheimers Dis. 2016. https:\/\/doi.org\/10.3233\/JAD-150514.","journal-title":"J Alzheimers Dis"},{"key":"1093_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/biom12030365","author":"P Kwan","year":"2022","unstructured":"Kwan P, Ho A, Baum L. Effects of deferasirox in Alzheimer\u2019s disease and tauopathy animal models. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12030365.","journal-title":"Biomolecules"},{"key":"1093_CR58","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2009-1068","author":"ML Hegde","year":"2009","unstructured":"Hegde ML, Bharathi P, Suram A, Venugopal C, Jagannathan R, Poddar P, Srinivas P, Sambamurti K, Rao KJ, Scancar J, Messori L, Zecca L, Zatta P. Challenges associated with metal chelation therapy in Alzheimer\u2019s disease. J Alzheimers Dis. 2009. https:\/\/doi.org\/10.3233\/JAD-2009-1068.","journal-title":"J Alzheimers Dis"},{"key":"1093_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2003.10.014","author":"S Daniel","year":"2004","unstructured":"Daniel S, Limson JL, Dairam A, Watkins GM, Daya S. Through metal binding, curcumin protects against lead- and cadmium-induced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain. J Inorg Biochem. 2004. https:\/\/doi.org\/10.1016\/j.jinorgbio.2003.10.014.","journal-title":"J Inorg Biochem"},{"key":"1093_CR60","doi-asserted-by":"publisher","DOI":"10.1021\/jf063446t","author":"A Dairam","year":"2007","unstructured":"Dairam A, Limson JL, Watkins GM, Antunes E, Daya S. Curcuminoids, curcumin, and demethoxycurcumin reduce lead-induced memory deficits in male Wistar rats. J Agric Food Chem. 2007. https:\/\/doi.org\/10.1021\/jf063446t.","journal-title":"J Agric Food Chem"},{"key":"1093_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2007.05.071","author":"Y Xu","year":"2007","unstructured":"Xu Y, Ku B, Cui L, Li X, Barish PA, Foster TC, Ogle WO. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res. 2007. https:\/\/doi.org\/10.1016\/j.brainres.2007.05.071.","journal-title":"Brain Res"},{"key":"1093_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2005.05.005","author":"A Barik","year":"2005","unstructured":"Barik A, Mishra B, Shen L, Mohan H, Kadam RM, Dutta S, Zhang HY, Priyadarsini KI. Evaluation of a new copper(II)-curcumin complex as superoxide dismutase mimic and its free radical reactions. Free Radic Biol Med. 2005. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2005.05.005.","journal-title":"Free Radic Biol Med"},{"key":"1093_CR63","doi-asserted-by":"publisher","DOI":"10.3233\/jad-2004-6403","author":"L Baum","year":"2004","unstructured":"Baum L, Ng A. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer\u2019s disease animal models. J Alzheimers Dis. 2004. https:\/\/doi.org\/10.3233\/jad-2004-6403.","journal-title":"J Alzheimers Dis"},{"key":"1093_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27123879","author":"H Yang","year":"2022","unstructured":"Yang H, Zeng F, Luo Y, Zheng C, Ran C, Yang J. Curcumin scaffold as a multifunctional tool for Alzheimer\u2019s disease research. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27123879.","journal-title":"Molecules"},{"key":"1093_CR65","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/81.1.313S","author":"JA Joseph","year":"2005","unstructured":"Joseph JA, Shukitt-Hale B, Casadesus G. Reversing the deleterious effects of aging on neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds. Am J Clin Nutr. 2005. https:\/\/doi.org\/10.1093\/ajcn\/81.1.313S.","journal-title":"Am J Clin Nutr"},{"key":"1093_CR66","doi-asserted-by":"publisher","DOI":"10.2174\/092986708785132979","author":"PV Babu","year":"2008","unstructured":"Babu PV, Liu D. Green tea catechins and cardiovascular health: an update. Curr Med Chem. 2008. https:\/\/doi.org\/10.2174\/092986708785132979.","journal-title":"Curr Med Chem"},{"key":"1093_CR67","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.02291.x","author":"S Mandel","year":"2004","unstructured":"Mandel S, Weinreb O, Amit T, Youdim MBH. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J Neurochem. 2004. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.02291.x.","journal-title":"J Neurochem"},{"key":"1093_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2020.128060","author":"YQ Xu","year":"2021","unstructured":"Xu YQ, Gao Y, Granato D. Effects of epigallocatechin gallate, epigallocatechin and epicatechin gallate on the chemical and cell-based antioxidant activity, sensory properties, and cytotoxicity of a catechin-free model beverage. Food Chem. 2021. https:\/\/doi.org\/10.1016\/j.foodchem.2020.128060.","journal-title":"Food Chem"},{"key":"1093_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104382","author":"T Chen","year":"2020","unstructured":"Chen T, Yang Y, Zhu S, Lu Y, Zhu L, Wang Y, Wang X. Inhibition of A\u03b2 aggregates in Alzheimer\u2019s disease by epigallocatechin and epicatechin-3-gallate from green tea. Bioorg Chem. 2020. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104382.","journal-title":"Bioorg Chem"},{"key":"1093_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2007.06.001","author":"S Mandel","year":"2007","unstructured":"Mandel S, Amit T, Bar-Am O, Youdim MBH. Iron dysregulation in Alzheimer\u2019s disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents. Prog Neurobiol. 2007. https:\/\/doi.org\/10.1016\/j.pneurobio.2007.06.001.","journal-title":"Prog Neurobiol"},{"key":"1093_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.651156","author":"M Jahanshahi","year":"2021","unstructured":"Jahanshahi M, Khalili M, Margedari A. Naringin chelates excessive iron and prevents the formation of amyloid-beta plaques in the hippocampus of iron-overloaded mice. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.651156.","journal-title":"Front Pharmacol"},{"key":"1093_CR72","doi-asserted-by":"publisher","DOI":"10.2174\/0929867321666140601161939","author":"M Tegoni","year":"2014","unstructured":"Tegoni M, Valensin D, Toso L, Remelli M. Copper chelators: chemical properties and bio-medical applications. Curr Med Chem. 2014. https:\/\/doi.org\/10.2174\/0929867321666140601161939.","journal-title":"Curr Med Chem"},{"key":"1093_CR73","doi-asserted-by":"publisher","DOI":"10.1023\/a:1020247323914","author":"RA Lovstad","year":"2002","unstructured":"Lovstad RA. A kinetic study on the copper-albumin catalyzed oxidation of ascorbate. Biometals. 2002. https:\/\/doi.org\/10.1023\/a:1020247323914.","journal-title":"Biometals"},{"key":"1093_CR74","doi-asserted-by":"publisher","DOI":"10.1021\/jm301053a","author":"S Tardito","year":"2012","unstructured":"Tardito S, Barilli A, Bassanetti I, Tegoni M, Bussolati O, Franchi-Gazzola R, Mucchino C, Marchi\u00f2 L. Copper-dependent cytotoxicity of 8-hydroxyquinoline derivatives correlates with their hydrophobicity and does not require caspase activation. J Med Chem. 2012. https:\/\/doi.org\/10.1021\/jm301053a.","journal-title":"J Med Chem"},{"key":"1093_CR75","doi-asserted-by":"publisher","DOI":"10.1021\/ic9014256","author":"AM Mancino","year":"2009","unstructured":"Mancino AM, Hindo SS, Kochi A, Lim MH. Effects of clioquinol on metal-triggered amyloid-\u03b2 aggregation revisited. Inorg Chem. 2009. https:\/\/doi.org\/10.1021\/ic9014256.","journal-title":"Inorg Chem"},{"key":"1093_CR76","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M602487200","author":"AR White","year":"2006","unstructured":"White AR, Du T, Laughton KM, Volitakis I, Sharples RA, Xilinas ME, Hoke DE, Holsinger RMD, Evin G, Cherny RA, Hill AF, Barnham KJ, Li QX, Bush AI, Masters CL. Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem. 2006. https:\/\/doi.org\/10.1074\/jbc.M602487200.","journal-title":"J Biol Chem"},{"key":"1093_CR77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2010.00231.x","author":"SR Bareggi","year":"2012","unstructured":"Bareggi SR, Cornelli U. Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. CNS Neurosci Ther. 2012. https:\/\/doi.org\/10.1111\/j.1755-5949.2010.00231.x.","journal-title":"CNS Neurosci Ther"},{"key":"1093_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/nm0409-356","author":"L Cahoon","year":"2009","unstructured":"Cahoon L. The curious case of clioquinol. Nat Med. 2009. https:\/\/doi.org\/10.1038\/nm0409-356.","journal-title":"Nat Med"},{"key":"1093_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.06.018","author":"PA Adlard","year":"2008","unstructured":"Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, Cortes M, Volitakis I, Liu X, Smith JP, Perez K, Laughton K, Li QX, Charman SA, Nicolazzo JA, Wilkins S, Deleva K, Lynch T, Kok G, Ritchie CW, Tanzi RE, Cappai R, Masters CL, Barnham KJ, Bush AI. Rapid restoration of cognition in Alzheimer\u2019s transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron. 2008. https:\/\/doi.org\/10.1016\/j.neuron.2008.06.018.","journal-title":"Neuron"},{"key":"1093_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70167-4","author":"L Lannfelt","year":"2008","unstructured":"Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J, Masters CL, Targum S, Bush AI, Murdoch R, Wilson J, Ritchie CW. Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer\u2019s disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2008. https:\/\/doi.org\/10.1016\/S1474-4422(08)70167-4.","journal-title":"Lancet Neurol"},{"key":"1093_CR81","doi-asserted-by":"publisher","DOI":"10.1039\/C2CS35236B","author":"MA Telpoukhovskaia","year":"2013","unstructured":"Telpoukhovskaia MA, Orvig C. Werner coordination chemistry and neurodegeneration. Chem Soc Rev. 2013. https:\/\/doi.org\/10.1039\/C2CS35236B.","journal-title":"Chem Soc Rev"},{"key":"1093_CR82","doi-asserted-by":"publisher","DOI":"10.1039\/B816577G","author":"L Bica","year":"2009","unstructured":"Bica L, Crouch PJ, Cappai R, White AR. Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer\u2019s disease. Mol Biosyst. 2009. https:\/\/doi.org\/10.1039\/B816577G.","journal-title":"Mol Biosyst"},{"key":"1093_CR83","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M407410200","author":"C Treiber","year":"2004","unstructured":"Treiber C, Simons A, Strauss M, Hafner M, Cappai R, Bayer TA, Multhaup G. Clioquinol mediates copper uptake and counteracts copper efflux activities of the amyloid precursor protein in Alzheimer\u2019s disease. J Biol Chem. 2004. https:\/\/doi.org\/10.1074\/jbc.M407410200.","journal-title":"J Biol Chem"},{"key":"1093_CR84","doi-asserted-by":"publisher","DOI":"10.1039\/B616085A","author":"C Deraeve","year":"2007","unstructured":"Deraeve C, Piti\u00e9 M, Mazarguil H, Meunier B. Bis-8-hydroxyquinoline ligands as potential anti-Alzheimer agents. New J Chem. 2007. https:\/\/doi.org\/10.1039\/B616085A.","journal-title":"New J Chem"},{"key":"1093_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/chem.200701024","author":"C Deraeve","year":"2008","unstructured":"Deraeve C, Boldron C, Maraval A, Mazarguil H, Gornitzka H, Vendier L, Piti\u00e9 M, Meunier B. Preparation and study of new poly-8-hydroxyquinoline chelators for an anti-Alzheimer strategy. Chemistry. 2008. https:\/\/doi.org\/10.1002\/chem.200701024.","journal-title":"Chemistry"},{"key":"1093_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/ejic.200800924","author":"C Deraeve","year":"2008","unstructured":"Deraeve C, Maraval A, Vendier L, Faugeroux V, Piti\u00e9 M, Meunier B. Preparation of new bis(8-aminoquinoline) ligands and comparison with bis(8-hydroxyquinoline) ligands on their ability to chelate CuII and ZnII. Eur J Inorg Chem. 2008. https:\/\/doi.org\/10.1002\/ejic.200800924.","journal-title":"Eur J Inorg Chem"},{"key":"1093_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/s0896-6273(01)00317-8","author":"RA Cherny","year":"2001","unstructured":"Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, Barnham KJ, Volitakis I, Fraser FW, Kim Y, Huang X, Goldstein LE, Moir RD, Lim JT, Beyreuther K, Zheng H, Tanzi RE, Masters CL, Bush AI. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer\u2019s disease transgenic mice. Neuron. 2001. https:\/\/doi.org\/10.1016\/s0896-6273(01)00317-8.","journal-title":"Neuron"},{"key":"1093_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.03.008","author":"C Rodr\u00edguez-Rodr\u00edguez","year":"2012","unstructured":"Rodr\u00edguez-Rodr\u00edguez C, Telpoukhovskaia M, Orvig C. The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases. Coord Chem Rev. 2012. https:\/\/doi.org\/10.1016\/j.ccr.2012.03.008.","journal-title":"Coord Chem Rev"},{"key":"1093_CR89","doi-asserted-by":"publisher","DOI":"10.1021\/cr9000176","author":"LE Scott","year":"2009","unstructured":"Scott LE, Orvig C. Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease. Chem Rev. 2009. https:\/\/doi.org\/10.1021\/cr9000176.","journal-title":"Chem Rev"},{"key":"1093_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2006.08.001","author":"P Frid","year":"2007","unstructured":"Frid P, Anisimov SV, Popovic N. Congo red and protein aggregation in neurodegenerative diseases. Brain Res Rev. 2007. https:\/\/doi.org\/10.1016\/j.brainresrev.2006.08.001.","journal-title":"Brain Res Rev"},{"key":"1093_CR91","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2011.01110.x","author":"AA Reinke","year":"2011","unstructured":"Reinke AA, Gestwicki JE. Insight into amyloid structure using chemical probes. Chem Biol Drug Des. 2011. https:\/\/doi.org\/10.1111\/j.1747-0285.2011.01110.x.","journal-title":"Chem Biol Drug Des"},{"key":"1093_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2010.06.044","author":"MC Hong","year":"2010","unstructured":"Hong MC, Kim YK, Choi JY, Yang SQ, Rhee H, Ryu YH, Choi TH, Cheon GJ, An GI, Kim HY, Kim Y, Kim DJ, Lee JS, Chang YT, Lee KC. Synthesis and evaluation of stilbene derivatives as a potential imaging agent of amyloid plaques. Bioorg Med Chem. 2010. https:\/\/doi.org\/10.1016\/j.bmc.2010.06.044.","journal-title":"Bioorg Med Chem"},{"key":"1093_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2007.07.052","author":"M Ono","year":"2007","unstructured":"Ono M, Haratake M, Mori H, Nakayama M. Novel chalcones as probes for in vivo imaging of beta-amyloid plaques in Alzheimer\u2019s brains. Bioorg Med Chem. 2007. https:\/\/doi.org\/10.1016\/j.bmc.2007.07.052.","journal-title":"Bioorg Med Chem"},{"key":"1093_CR94","first-page":"748","volume":"47","author":"AB Newberg","year":"2006","unstructured":"Newberg AB, Wintering NA, Pl\u00f6ssl K, Hochold J, Stabin MG, Watson M, Skovronsky D, Clark CM, Kung MP, Kung HF. Safety, biodistribution and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer\u2019s disease. J Nucl Med. 2006;47:748\u201354.","journal-title":"J Nucl Med"},{"key":"1093_CR95","doi-asserted-by":"publisher","DOI":"10.1021\/ml300058m","author":"HF Kung","year":"2012","unstructured":"Kung HF. The \u03b2-Amyloid Hypothesis in Alzheimer\u2019s disease: seeing is believing. ACS Med Chem Lett. 2012. https:\/\/doi.org\/10.1021\/ml300058m.","journal-title":"ACS Med Chem Lett"},{"key":"1093_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.11.058","author":"M Ono","year":"2011","unstructured":"Ono M, Watanabe H, Watanabe R, Haratake M, Nakayama M, Saji H. Diphenylpropynone derivatives as probes for imaging \u03b2-amyloid plaques in Alzheimer\u2019s brains. Bioorg Med Chem Lett. 2011. https:\/\/doi.org\/10.1016\/j.bmcl.2010.11.058.","journal-title":"Bioorg Med Chem Lett"},{"key":"1093_CR97","doi-asserted-by":"publisher","DOI":"10.1021\/ic302084g","author":"AS Pithadia","year":"2012","unstructured":"Pithadia AS, Kochi A, Soper MT, Beck MW, Liu Y, Lee S, DeToma AS, Ruotolo BT, Lim MH. Reactivity of diphenylpropyone derivatives toward metal-associated amyloid-\u03b2 species. Inorg Chem. 2012. https:\/\/doi.org\/10.1021\/ic302084g.","journal-title":"Inorg Chem"},{"key":"1093_CR98","doi-asserted-by":"publisher","DOI":"10.1021\/ja806062g","author":"C Rodr\u00edguez-Rodr\u00edguez","year":"2009","unstructured":"Rodr\u00edguez-Rodr\u00edguez C, De Groot NS, Rimola A, \u00c1lvarez-Larena AN, Lloveras V, Vidal-Gancedo J, Ventura S, Vendrell J, Sodupe M, Gonz\u00e1lez-Duarte P. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer\u2019s disease. J Am Chem Soc. 2009. https:\/\/doi.org\/10.1021\/ja806062g.","journal-title":"J Am Chem Soc"},{"key":"1093_CR99","doi-asserted-by":"publisher","DOI":"10.1021\/jm3003813","author":"J Geng","year":"2012","unstructured":"Geng J, Li M, Wu L, Ren J, Qu X. Liberation of copper from amyloid plaques: making a risk factor useful for Alzheimer\u2019s disease treatment. J Med Chem. 2012. https:\/\/doi.org\/10.1021\/jm3003813.","journal-title":"J Med Chem"},{"key":"1093_CR100","doi-asserted-by":"publisher","DOI":"10.1021\/ja409801p","author":"S Lee","year":"2014","unstructured":"Lee S, Zheng X, Krishnamoorthy J, Savelieff MG, Park HM, Brender JR, Kim JH, Derrick JS, Kochi A, Lee HJ, Kim C, Ramamoorthy A, Bowers MT, Lim MH. Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer\u2019s disease. J Am Chem Soc. 2014. https:\/\/doi.org\/10.1021\/ja409801p.","journal-title":"J Am Chem Soc"},{"key":"1093_CR101","doi-asserted-by":"publisher","DOI":"10.1039\/c0mt00077a","author":"JS Choi","year":"2011","unstructured":"Choi JS, Braymer JJ, Park SK, Mustafa S, Chae J, Lim MH. Synthesis and characterization of IMPY derivatives that regulate metal-induced amyloid-\u03b2 aggregation. Metallomics. 2011. https:\/\/doi.org\/10.1039\/c0mt00077a.","journal-title":"Metallomics"},{"key":"1093_CR102","doi-asserted-by":"publisher","DOI":"10.1021\/ic2012205","author":"JJ Braymer","year":"2011","unstructured":"Braymer JJ, Choi JS, DeToma AS, Wang C, Nam K, Kampf JW, Ramamoorthy A, Lim MH. Development of bifunctional stilbene derivatives for targeting and modulating metal-amyloid-\u03b2 species. Inorg Chem. 2011. https:\/\/doi.org\/10.1021\/ic2012205.","journal-title":"Inorg Chem"},{"key":"1093_CR103","doi-asserted-by":"publisher","DOI":"10.1021\/ja907045h","author":"SS Hindo","year":"2009","unstructured":"Hindo SS, Mancino AM, Braymer JJ, Liu Y, Vivekanandan S, Ramamoorthy A, Lim MH. Small molecule modulators of copper-induced A\u03b2 aggregation. J Am Chem Soc. 2009. https:\/\/doi.org\/10.1021\/ja907045h.","journal-title":"J Am Chem Soc"},{"key":"1093_CR104","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1006091107","author":"JS Choi","year":"2010","unstructured":"Choi JS, Braymer JJ, Nanga RPR, Ramamoorthy A, Lim MH. Design of small molecules that targer metal-A{beta} species and regulate metal-induced A{beta} aggregation and neurotoxicity. Proc Natl Acad Sci U S A. 2010. https:\/\/doi.org\/10.1073\/pnas.1006091107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1093_CR105","doi-asserted-by":"publisher","DOI":"10.1039\/c2mt20113e","author":"MR Jones","year":"2012","unstructured":"Jones MR, Service EL, Thompson JR, Wang MCP, Kimsey IJ, DeToma AS, Ramamoorthy A, Lim MH, Storr T. Dual-function triazole-pyridine derivatives as inhibitors of metal-induced amyloid-\u03b2 aggregation. Metallomics. 2012. https:\/\/doi.org\/10.1039\/c2mt20113e.","journal-title":"Metallomics"},{"key":"1093_CR106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2008.06643.x","author":"A Wahlstr\u00f6m","year":"2008","unstructured":"Wahlstr\u00f6m A, Hugonin L, Per\u00e1lvarez-Mar\u00edn A, Jarvet J, Gr\u00e4slund A. Secondary structure conversions of Alzheimer\u2019s A\u03b2(1\u201340) peptide induced by membrane-mimicking detergents. FEBS J. 2008. https:\/\/doi.org\/10.1111\/j.1742-4658.2008.06643.x.","journal-title":"FEBS J"},{"key":"1093_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2012.01.016","author":"AS Pithadia","year":"2012","unstructured":"Pithadia AS, Lim MH. Metal-associated amyloid-\u03b2 species in Alzheimer\u2019s disease. Curr Opin Chem Biol. 2012. https:\/\/doi.org\/10.1016\/j.cbpa.2012.01.016.","journal-title":"Curr Opin Chem Biol"},{"key":"1093_CR108","doi-asserted-by":"publisher","DOI":"10.1039\/C1DT00020A","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Chen LY, Yin WX, Yin J, Zhang SB, Liu CL. The chelation targeting metal-A\u03b240 aggregates may lead to formation of A\u03b240 oligomers. Dalton Trans. 2011. https:\/\/doi.org\/10.1039\/C1DT00020A.","journal-title":"Dalton Trans"},{"key":"1093_CR109","doi-asserted-by":"publisher","DOI":"10.1021\/ja210588m","author":"AK Sharma","year":"2012","unstructured":"Sharma AK, Pavlova ST, Kim J, Finkelstein D, Hawco NJ, Rath NP, Kim J, Mirica LM. Bifunctional compounds for controlling metal-mediated aggregation of the a\u03b242 peptide. J Am Chem Soc. 2012. https:\/\/doi.org\/10.1021\/ja210588m.","journal-title":"J Am Chem Soc"},{"key":"1093_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2004.08.016","author":"A Dedeoglu","year":"2004","unstructured":"Dedeoglu A, Cormier K, Payton S, Tseitlin KA, Kremsky JN, Lai L, Li X, Moir RD, Tanzi RE, Bush AI, Kowall NW, Rogers JT, Huang X. Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer\u2019s amyloidogenesis. Exp Gerontol. 2004. https:\/\/doi.org\/10.1016\/j.exger.2004.08.016.","journal-title":"Exp Gerontol"},{"key":"1093_CR111","doi-asserted-by":"publisher","DOI":"10.1039\/C0SC00544D","author":"LE Scott","year":"2011","unstructured":"Scott LE, Telpoukhovskaia M, Rodr\u00edguez-Rodr\u00edguez C, Merkel M, Bowen ML, Page BDG, Grenn DE, Storr T, Thomas F, Allen DD, Lockman PR, Patrick BO, Adam MJ, Orvig C. N-Aryl substituted 3-(\u03b2-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer\u2019s therapy. Chem Sci. 2011. https:\/\/doi.org\/10.1039\/C0SC00544D.","journal-title":"Chem Sci"},{"key":"1093_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2013.10.020","author":"GI Grasso","year":"2014","unstructured":"Grasso GI, Arena G, Bellia F, Rizzarelli E, Vecchio G. Copper(II)-chelating homocarnosine glycoconjugate as a new multifunctional compound. J Inorg Biochem. 2014. https:\/\/doi.org\/10.1016\/j.jinorgbio.2013.10.020.","journal-title":"J Inorg Biochem"},{"key":"1093_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2005.02.003","author":"R Liu","year":"2005","unstructured":"Liu R, Barkhordarian H, Emadi S, Park CB, Sierks MR. Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42. Neurobiol Dis. 2005. https:\/\/doi.org\/10.1016\/j.nbd.2005.02.003.","journal-title":"Neurobiol Dis"},{"key":"1093_CR114","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-023-10651-5","author":"RX Tan","year":"2023","unstructured":"Tan RX, Li WH, Pang JM, Zhong SM, Huang XY, Deng JZ, Zhou LY, Wu JQ, Wang XQ. Design, synthesis, and evaluation of 2,2\u2032-bipyridyl derivatives as bifunctional agents against Alzheimer\u2019s disease. Mol Divers. 2023. https:\/\/doi.org\/10.1007\/s11030-023-10651-5.","journal-title":"Mol Divers"},{"key":"1093_CR115","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.0c00621","author":"J Zhao","year":"2021","unstructured":"Zhao J, Shi Q, Tian H, Li Y, Liu Y, Xu Z, Robert A, Liu Q, Meunier B. TDMQ20, a specific copper chelator, reduces memory impairments in Alzheimer\u2019s disease mouse models. ACS Chem Neurosci. 2021. https:\/\/doi.org\/10.1021\/acschemneuro.0c00621.","journal-title":"ACS Chem Neurosci"},{"key":"1093_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2021.111393","author":"N Pavlidis","year":"2021","unstructured":"Pavlidis N, Kofinas A, Papanikolaou MG, Miras HN, Drouza C, Kalampounias AG, Kabanos TA, Konstandi M, Leondaritis G. Synthesis, characterization and pharmacological evaluation of quinoline derivatives and their complexes with copper(II) in in vitro cell models of Alzheimer\u2019s disease. J Inorg Biochem. 2021. https:\/\/doi.org\/10.1016\/j.jinorgbio.2021.111393.","journal-title":"J Inorg Biochem"},{"key":"1093_CR117","doi-asserted-by":"publisher","DOI":"10.1007\/s00775-023-02013-1","author":"E Crnich","year":"2023","unstructured":"Crnich E, Sanchez E, Havens MA, Kissel DS. Sulfur-bridging the gap: investigating the electrochemistry of novel copper chelating agents for Alzheimer\u2019s disease applications. J Biol Inorg Chem. 2023. https:\/\/doi.org\/10.1007\/s00775-023-02013-1.","journal-title":"J Biol Inorg Chem"},{"key":"1093_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2013.01.009","author":"RJ Radford","year":"2013","unstructured":"Radford RJ, Lippard SJ. Chelators for investigating zinc metalloneurochemistry. Curr Opin Chem Biol. 2013. https:\/\/doi.org\/10.1016\/j.cbpa.2013.01.009.","journal-title":"Curr Opin Chem Biol"},{"key":"1093_CR119","doi-asserted-by":"publisher","DOI":"10.1039\/b926662c","author":"RA Colvin","year":"2010","unstructured":"Colvin RA, Holmes WR, Fontaine CP, Maret W. Cytosolic zinc buffering and muffling: their role in intracellular zinc homeostasis. Metallomics. 2010. https:\/\/doi.org\/10.1039\/b926662c.","journal-title":"Metallomics"},{"key":"1093_CR120","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3454-11.2011","author":"SL Sensi","year":"2011","unstructured":"Sensi SL, Paoletti P, Koh JY, Aizenman E, Bush AI, Hershfinkel M. The neurophysiology and pathology of brain zinc. J Neurosci. 2011. https:\/\/doi.org\/10.1523\/JNEUROSCI.3454-11.2011.","journal-title":"J Neurosci"},{"key":"1093_CR121","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-nutr-072610-145218","author":"K T\u00f3th","year":"2011","unstructured":"T\u00f3th K. Zinc in neurotransmission. Annu Rev Nutr. 2011. https:\/\/doi.org\/10.1146\/annurev-nutr-072610-145218.","journal-title":"Annu Rev Nutr"},{"key":"1093_CR122","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C111.320796","author":"M Wilson","year":"2012","unstructured":"Wilson M, Hogstrand C, Maret W. Picomolar concentrations of free zinc(II) ions regulate receptor protein-tyrosine phosphatase beta activity. J Biol Chem. 2012. https:\/\/doi.org\/10.1074\/jbc.C111.320796.","journal-title":"J Biol Chem"},{"key":"1093_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2009.338","author":"E Karakas","year":"2009","unstructured":"Karakas E, Simorowski N, Furukawa H. Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit. EMBO J. 2009. https:\/\/doi.org\/10.1038\/emboj.2009.338.","journal-title":"EMBO J"},{"key":"1093_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2007.11.026","author":"YZ Huang","year":"2008","unstructured":"Huang YZ, Pan E, Xiong ZQ, McNamara JO. Zinc-mediated transactivation of TrkB potentiates the hippocampal mossy fiber-CA3 pyramid synapse. Neuron. 2008. https:\/\/doi.org\/10.1016\/j.neuron.2007.11.026.","journal-title":"Neuron"},{"key":"1093_CR125","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0755-12.2012","author":"YZ Huang","year":"2012","unstructured":"Huang YZ, McNamara JO. Neuroprotective effects of reactive oxygen species mediated by BDNF-independent activation of TrkB. J Neurosci. 2012. https:\/\/doi.org\/10.1523\/JNEUROSCI.0755-12.2012.","journal-title":"J Neurosci"},{"key":"1093_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.08.027","author":"J Veran","year":"2012","unstructured":"Veran J, Kumar J, Pinheiro PS, Athane A, Mayer ML, Perrais D, Mulle C. Zinc potentiates GluK3 glutamate receptor function by stabilizing the ligand binding domain dimer interface. Neuron. 2012. https:\/\/doi.org\/10.1016\/j.neuron.2012.08.027.","journal-title":"Neuron"},{"key":"1093_CR127","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2011-111874","author":"T Wang","year":"2012","unstructured":"Wang T, Wang CY, Shan ZY, Teng WP, Wang ZY. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AbetaPP\/PS1 transgenic mouse brain. J Alzheimers Dis. 2012. https:\/\/doi.org\/10.3233\/JAD-2011-111874.","journal-title":"J Alzheimers Dis"},{"key":"1093_CR128","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2010-1390","author":"NG Faux","year":"2010","unstructured":"Faux NG, Ritchie CW, Gunn A, Rembach A, Tsatsanis A, Bedo J, Harrison J, Lannfelt L, Blennow K, Zetterberg H, Ingelsson M, Masters CL, Tanzi RE, Cummings JL, Herd CM, Bush AI. PBT2 rapidly improves cognition in Alzheimer\u2019s disease: additional phase II analyses. J Alzheimers Dis. 2010. https:\/\/doi.org\/10.3233\/JAD-2010-1390.","journal-title":"J Alzheimers Dis"},{"key":"1093_CR129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017971","author":"C Corona","year":"2011","unstructured":"Corona C, Frazzini V, Silvestri E, Lattanzio R, La Sorda R, Piantelli M, Canzoniero LMT, Ciavardelli D, Rizzarelli E, Sensi SL. Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice. PLoS\u00a0One. 2011. https:\/\/doi.org\/10.1371\/journal.pone.0017971.","journal-title":"PLoS\u00a0One"},{"key":"1093_CR130","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M705957200","author":"PS Donnelly","year":"2008","unstructured":"Donnelly PS, Caragounis A, Du T, Laughton KM, Volitakis I, Cherny RA, Sharples RA, Hill AF, Li QX, Masters CL, Barnham KJ, White AR. Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide. J Biol Chem. 2008. https:\/\/doi.org\/10.1074\/jbc.M705957200.","journal-title":"J Biol Chem"},{"key":"1093_CR131","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.163964","author":"MA Greenough","year":"2011","unstructured":"Greenough MA, Volitakis I, Li QX, Laughton K, Evin G, Ho M, Dalziel AH, Camakaris J, Bush AI. Presenilins promote the cellular uptake of copper and zinc and maintain copper chaperone of SOD1-dependent copper\/zinc superoxide dismutase activity. J Biol Chem. 2011. https:\/\/doi.org\/10.1074\/jbc.M110.163964.","journal-title":"J Biol Chem"},{"key":"1093_CR132","doi-asserted-by":"publisher","DOI":"10.1021\/ja00905a001","author":"RG Pearson","year":"1963","unstructured":"Pearson RG. Hard and soft acids and bases. J Am Chem Soc. 1963. https:\/\/doi.org\/10.1021\/ja00905a001.","journal-title":"J Am Chem Soc"},{"key":"1093_CR133","doi-asserted-by":"publisher","DOI":"10.1021\/ic990904p","author":"EA Ambundo","year":"2000","unstructured":"Ambundo EA, Deydier MV, Ochrymowycz LA, Rorabacher DB. Kinetics and mechanism of copper(II) complex formation with tripodal aminopolythiaether and aminopolypyridyl ligands in aqueous solution. Inorg Chem. 2000. https:\/\/doi.org\/10.1021\/ic990904p.","journal-title":"Inorg Chem"},{"key":"1093_CR134","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21411","author":"Y Yang","year":"2007","unstructured":"Yang Y, Kawataki T, Fukui K, Koike T. Cellular Zn2+ chelators cause \u201cdying-back\u201d neurite degeneration associated with energy impairment. J Neurosci Res. 2007. https:\/\/doi.org\/10.1002\/jnr.21411.","journal-title":"J Neurosci Res"},{"key":"1093_CR135","doi-asserted-by":"publisher","DOI":"10.1021\/ic2025236","author":"JW Meeusen","year":"2012","unstructured":"Meeusen JW, Nowakowski A, Petering DH. Reaction of metal-binding ligands with the zinc proteome: zinc sensors and N, N, N\u2032, N\u2032-tetrakis(2-pyridylmethyl)ethylenediamine. Inorg Chem. 2012. https:\/\/doi.org\/10.1021\/ic2025236.","journal-title":"Inorg Chem"},{"key":"1093_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2008.04.056","author":"JM Lee","year":"2008","unstructured":"Lee JM, Kim YJ, Ra H, Kang SJ, Han S, Koh JY, Kim YH. The involvement of caspase-11 in TPEN-induced apoptosis. FEBS Lett. 2008. https:\/\/doi.org\/10.1016\/j.febslet.2008.04.056.","journal-title":"FEBS Lett"},{"key":"1093_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2011.09.013","author":"RE Carraway","year":"2012","unstructured":"Carraway RE, Dobner PR. Zinc pyrithione induces ERK- and PKC-dependent necrosis distinct from TPEN-induced apoptosis in prostate cancer cells. Biochim Biophys Acta. 2012. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.09.013.","journal-title":"Biochim Biophys Acta"},{"key":"1093_CR138","doi-asserted-by":"publisher","DOI":"10.1039\/b919237a","author":"LR Perez","year":"2010","unstructured":"Perez LR, Franz KJ. Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease. Dalton Trans. 2010. https:\/\/doi.org\/10.1039\/b919237a.","journal-title":"Dalton Trans"},{"key":"1093_CR139","doi-asserted-by":"publisher","DOI":"10.1002\/anie.200603866","author":"H Schugar","year":"2007","unstructured":"Schugar H, Green DE, Bowen ML, Scott LE, Storr T, Bohmerle K, Thomas F, Allen DD, Lockman PR, Merkel M, Thompson KH, Orvig C. Combating Alzheimer\u2019s disease with multifunctional molecules designed for metal passivation. Angew Chem Int Ed. 2007. https:\/\/doi.org\/10.1002\/anie.200603866.","journal-title":"Angew Chem Int Ed"},{"key":"1093_CR140","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M804722200","author":"WH Wu","year":"2008","unstructured":"Wu WH, Lei P, Liu Q, Hu J, Gunn AP, Chen MS, Rui YF, Su XY, Xie ZP, Zhao YF, Bush AI, Li YM. Sequestration of copper from beta-amyloid promotes selective lysis by cyclen-hybrid cleavage agents. J Biol Chem. 2008. https:\/\/doi.org\/10.1074\/jbc.M804722200.","journal-title":"J Biol Chem"},{"key":"1093_CR141","doi-asserted-by":"publisher","DOI":"10.1126\/stke.119re3","author":"AR Kay","year":"2008","unstructured":"Kay AR, Toth K. Is zinc a neuromodulator? Sci Signal. 2008. https:\/\/doi.org\/10.1126\/stke.119re3.","journal-title":"Sci Signal"},{"key":"1093_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2008.01.061","author":"P Paoletti","year":"2009","unstructured":"Paoletti P, Vergnano AM, Barbour B, Casado M. Zinc at glutamatergic synapses. Neuroscience. 2009. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.01.061.","journal-title":"Neuroscience"},{"key":"1093_CR143","doi-asserted-by":"publisher","DOI":"10.1021\/ja044697q","author":"E Kawabata","year":"2005","unstructured":"Kawabata E, Kikuchi K, Urano Y, Kojima H, Odani A, Nagano T. Design and synthesis of zinc-selective chelators for extracellular applications. J Am Chem Soc. 2005. https:\/\/doi.org\/10.1021\/ja044697q.","journal-title":"J Am Chem Soc"},{"key":"1093_CR144","doi-asserted-by":"publisher","DOI":"10.1021\/jo702394v","author":"XA Zhang","year":"2008","unstructured":"Zhang XA, Song D, Lippard SJ. A reversible pH-dependent intramolecular pyridine-aldehyde cyclization. J Org Chem. 2008. https:\/\/doi.org\/10.1021\/jo702394v.","journal-title":"J Org Chem"},{"key":"1093_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.811080","author":"M Aalikhani","year":"2022","unstructured":"Aalikhani M, Safdari Y, Jahanshahi M, Alikhani M, Khalili M. Comparison between hesperidin, coumarin and deferoxamine iron chelation and antioxidant activity against excessive iron in the iron overloaded mice. Front Neurosci. 2022. https:\/\/doi.org\/10.3389\/fnins.2021.811080.","journal-title":"Front Neurosci"},{"key":"1093_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.bfopcu.2017.05.001","author":"O Mazimba","year":"2017","unstructured":"Mazimba O. Umbelliferone: sources, chemistry and bioactivities review. Bull Fac Pharm Cairo Univ. 2017. https:\/\/doi.org\/10.1016\/j.bfopcu.2017.05.001.","journal-title":"Bull Fac Pharm Cairo Univ."},{"key":"1093_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2017.11.014","author":"MC Catapano","year":"2018","unstructured":"Catapano MC, Karl\u00ed\u010dkov\u00e1 J, Tvrd\u00fd V, Sharma S, Prasad AK, Saso L, Chhillar AK, Kune\u0161 J, Pour M, Parmar VS, Mlad\u011bnka P. Mono and dihydroxy coumarin derivatives: copper chelation and reduction ability. J Trace Elem Med Biol. 2018. https:\/\/doi.org\/10.1016\/j.jtemb.2017.11.014.","journal-title":"J Trace Elem Med Biol"},{"key":"1093_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2009.11.022","author":"R Singh","year":"2010","unstructured":"Singh R, Singh B, Singh S, Kumar N, Kumar S, Arora S. Umbelliferone\u2014an antioxidant isolated from Acacia nilotica (L.) Willd. Ex. Del. Food Chem. 2010. https:\/\/doi.org\/10.1016\/j.foodchem.2009.11.022.","journal-title":"Food Chem"},{"key":"1093_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2011.07.006","author":"O Mazimba","year":"2011","unstructured":"Mazimba O, Majinda RRT, Modibedi C, Masesane IB, Cencic A, Chingwaru W. Tylosema esculentum extractives and their bioactivity. Bioorg Med Chem. 2011. https:\/\/doi.org\/10.1016\/j.bmc.2011.07.006.","journal-title":"Bioorg Med Chem"},{"key":"1093_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.09.003","author":"G Kanimozhi","year":"2011","unstructured":"Kanimozhi G, Prasad NR, Ramachandran S, Pugalendi KV. Umbelliferone modulates gamma-radiation induced reactive oxygen species generation and subsequent oxidative damage in human blood lymphocytes. Eur J Pharmacol. 2011. https:\/\/doi.org\/10.1016\/j.ejphar.2011.09.003.","journal-title":"Eur J Pharmacol"},{"key":"1093_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2010.03.025","author":"P Mlad\u011bnka","year":"2010","unstructured":"Mlad\u011bnka P, Mac\u00e1kov\u00e1 K, Zatloukalov\u00e1 L, Reh\u00e1kov\u00e1 Z, Singh BK, Prasad AK, Parmar VS, Jahodar L, Hrdina R, Saso L. In vitro interactions of coumarins with iron. Biochimie. 2010. https:\/\/doi.org\/10.1016\/j.biochi.2010.03.025.","journal-title":"Biochimie"},{"key":"1093_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2023.341818","author":"X Kou","year":"2023","unstructured":"Kou X, Hu C, Pang Z, Zhang X, Wang H, Shen R, Yang A. A coumarin-based multifunctional chemosensor for Cu2+\/Al3+ as an AD theranostic agent: synthesis, X-ray single crystal analysis and activity study. Anal Chim Acta. 2023. https:\/\/doi.org\/10.1016\/j.aca.2023.341818.","journal-title":"Anal Chim Acta"},{"key":"1093_CR153","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202200867","author":"H Wang","year":"2023","unstructured":"Wang H, Su M, Shi X, Li X, Zhang X, Yang A, Shen R. Design, synthesis, calculation and biological activity studies based on privileged coumarin derivatives as multifunctional anti-ad lead compound. Chem Biodivers. 2023. https:\/\/doi.org\/10.1002\/cbdv.202200867.","journal-title":"Chem Biodivers"},{"key":"1093_CR154","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.2c08014","author":"DX Du","year":"2023","unstructured":"Du DX, Khang NHD, Tri NH, Nam PC, Thong NM. Exploring the multitarget activity of wedelolactone against Alzheimer\u2019s disease: insights from in silico study. ACS Omega. 2023. https:\/\/doi.org\/10.1021\/acsomega.2c08014.","journal-title":"ACS Omega"},{"key":"1093_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.07.031","author":"C Zhang","year":"2019","unstructured":"Zhang C, Yang K, Yu S, Su J, Yuan S, Han J, Chen Y, Gu J, Zhou T, Bai R, Xie Y. Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer\u2019s disease. Eur J Med Chem. 2019. https:\/\/doi.org\/10.1016\/j.ejmech.2019.07.031.","journal-title":"Eur J Med Chem"},{"key":"1093_CR156","doi-asserted-by":"publisher","DOI":"10.1039\/C0MT00087F","author":"RC Hider","year":"2011","unstructured":"Hider RC, Roy S, Ma YM, Le Kong X, Preston J. The potential application of iron chelators for the treatment of neurodegenerative diseases. Metallomics. 2011. https:\/\/doi.org\/10.1039\/C0MT00087F.","journal-title":"Metallomics"},{"key":"1093_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.01.003","author":"AC Tripathi","year":"2018","unstructured":"Tripathi AC, Upadhyay S, Paliwal S, Saraf SK. Privileged scaffolds as MAO inhibitors: retrospect and prospects. Eur J Med Chem. 2018. https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.003.","journal-title":"Eur J Med Chem"},{"key":"1093_CR158","doi-asserted-by":"publisher","DOI":"10.1021\/jm501690r","author":"S Carradori","year":"2015","unstructured":"Carradori S, Silvestri R. New frontiers in selective human MAO-B inhibitors. J Med Chem. 2015. https:\/\/doi.org\/10.1021\/jm501690r.","journal-title":"J Med Chem"},{"key":"1093_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2015.04.020","author":"CA Cobb","year":"2015","unstructured":"Cobb CA, Cole MP. Oxidative and nitrative stress in neurodegeneration. Neurobiol Dis. 2015. https:\/\/doi.org\/10.1016\/j.nbd.2015.04.020.","journal-title":"Neurobiol Dis"},{"key":"1093_CR160","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aav0316","author":"JH Park","year":"2019","unstructured":"Park JH, Ju YH, Choi JW, Song HJ, Jang BK, Woo J, Chun H, Kim HJ, Shin SJ, Yarishkin O, Jo S, Park M, Yeon SK, Kim S, Kim J, Nam MH, Londhe AM, Kim J, Cho SJ, Cho S, Lee C, Hwang SY, Kim SW, Oh SJ, Cho J, Pae AN, Lee CJ, Park KD. Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer\u2019s disease. Sci Adv. 2019. https:\/\/doi.org\/10.1126\/sciadv.aav0316.","journal-title":"Sci Adv"},{"key":"1093_CR161","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2019.1634703","author":"Z Mi","year":"2019","unstructured":"Mi Z, Gan B, Yu S, Guo J, Zhang C, Jiang X, Zhou T, Su J, Bai R, Xie Y. Dual-target anti-Alzheimer\u2019s disease agents with both iron ion-chelating and monoamine oxidase-B inhibitory activity. J Enzyme Inhib Med Chem. 2019. https:\/\/doi.org\/10.1080\/14756366.2019.1634703.","journal-title":"J Enzyme Inhib Med Chem"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01093-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-024-01093-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01093-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T07:21:44Z","timestamp":1718608904000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-024-01093-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":161,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1093"],"URL":"https:\/\/doi.org\/10.1007\/s40263-024-01093-0","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]},"assertion":[{"value":"29 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by The Ministry of Education, Science, Research and Sport of the Slovak Republic in cooperation with Centre for Scientific and Technical Information of the Slovak Republic. Provided by the Grant Agency for Science of the Slovak Ministry of Education (Grant no. 1\/0037\/22).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interests to declare in relation to the contents of this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for pulication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Both authors have contributed equally to this work in terms of conceptualization, review of literature, writing, and draft revision. Both authors have also read and approved the final submitted manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}